There are 2867 resources available
395P - Prevalence of clinically diagnosed depression among patients undergoing treatment for bowel cancer
Presenter: Gayathri Delanerolle
Session: Poster session 08
396P - Impact of depth of response of induction therapy on consecutive maintenance therapy in patients with RAS wild-type metastatic colorectal cancer: An analysis of the PanaMa trial (AIO KRK 0212)
Presenter: Greta Sommerhäuser
Session: Poster session 08
397P - Early decreases in KRAS mutant allele frequency (MAF) predicts clinical benefit to the PLK1 inhibitor onvansertib in combination with FOLFIRI/bev in 2L treatment of metastatic colorectal carcinoma (mCRC)
Presenter: Heinz-Josef Lenz
Session: Poster session 08
398P - Effectiveness and safety of regorafenib and trifluridine/tipiracil in refractory metastatic colorectal cancer: A real-world multicenter retrospective study with focus on sequential treatment
Presenter: Carlo Signorelli
Session: Poster session 08
399P - Role of geriatric assessment and oncological multidimensional prognostic index in elderly patients with metastatic colorectal cancer in a real-world setting
Presenter: Francesca Bergamo
Session: Poster session 08
400P - Impact of regorafenib dose optimization on comparative outcomes in the treatment of relapsed/refractory metastatic colorectal cancer (mCRC)
Presenter: Heather Burnett
Session: Poster session 08
401P - PROMETCO study: Metastatic colorectal cancer treatment patterns of the first 531 enrolled patients
Presenter: Jean-Baptiste Bachet
Session: Poster session 08
403P - First-line anti-EGFR therapy, patient characteristics and survival: Results from South Australian (SA) metastatic colorectal registry (mCRCR)
Presenter: Timothy Price
Session: Poster session 08
404P - A quantitative synthesis of disparities in the inclusion of younger adults and racial/ethnic minorities in colorectal cancer clinical trials
Presenter: Irbaz Riaz
Session: Poster session 08